Trends in Clinical Trials in India

							                                Trends in Clinical Trials in India


Clinical trials are a huge and booming sector of the Indian healthcare industry. The rise in its
development owing to enhanced education systems and medical architecture and information
technology sector is driving India to become a clinical trial hub. There are new medical companies and
CRO (clinical research organizations) that are commencing their operations in India and are conducting
clinical trials on new products for instance stem cells, nanotechnology based products, Biotech products
and many more. The government regulations concerning clinical trials too are becoming more rigid and
are going to make the approval process more simplified.


The 21st century has ushered in various upcoming domains in the healthcare industry. It has witnessed
the clinical trial industry getting into an alliance with the IT industry that is helping it to become the
biggest profit making industry round the globe. It is the only industry that has survived amidst the
global meltdown. This is very evident from the business that has been generated back in 2009 of
approximately 250 – 300 billions. The forces that have been driving behind this progress are the human
quest for better medical treatment and knowledge.


Apart from this, in the past few years the expense of inventing new drugs has been rising because of
the global inflation and has increased from $ 802 million in 2003 to about $1.2 billion in 2010. Owing to
this heavy expense companies around the globe are witnessing more on the development of existing
drugs with fresh dosage forms. In 2011 Norman Goldfarb conducted a quarterly review of the clinical
trial industry and asserted that the industry is moving towards a bright future with numerous medical
companies foraying into the medical sector.


From the regulatory services perspective, conducting clinical trials needs certain sanctions and
approvals. Owing to the developing medical scenario today might become a little complex a clinical
research organization or researcher to comply with all the regulation and guidelines. It is also similar
to the situation of enrolling and locating the subjects for trials. The Central Drug Standards Control
Organization (CDSCO) has released a new guidance concerning clinical trial approvals and new the
drugs in 2011. Therefore, regulatory services in India are becoming more stringent as per the bioethics
principles.
Furthermore, there are fresh technologies on which medical research is being carried on that comprises
transgenic animals, protein chips, stem cells, Bioinformatics, biometrics, medical devices, functional
genomics, Pharmacogenomics, molecular modeling, Chemoinformatics, proteomics, protein modeling
and many more.


Read More About: Clinical Pharmacokinetic, Bioavailability